PubMed HealthSearch

Biomedical subjects

A W Sparrow

Publications and source records attributed to A W Sparrow.

13 recordsLinked to original sources

Transport of poly-beta-hydroxybutyrate in human plasma.

Poly-beta-hydroxybutyrate (PHB) is an amphiphilic lipid that has been found to be a ubiquitous component of the cellular membranes of bacteria, plants and animals. The distribution of PHB in human plasma was investigated using chemical and immunological methods. PHB concentrations proved highly variable; in a random group of 24 blood donors, total plasma PHB ranged from 0.60 to 18.2 mg/l, with a mean of 3.5 mg/l. In plasma separated by density gradient ultracentrifugation, lipoproteins carried 20-30% of total plasma PHB; 6-14% in the very low density lipoproteins (VLDL), 8-16% in the low density lipoproteins (LDL), and less than 3% in the high density lipoproteins (HDL). The majority of plasma PHB (70-80%) was found in protein fractions of density greater than 1.22 g/ml. Western blot analysis of the high density fractions with anti-PHB F(ab')2 identified albumin as the major PHB-binding protein. The affinity of albumin for PHB was confirmed by in vitro studies which demonstrated transfer of 14C-PHB from chloroform into aqueous solutions of human and bovine serum albumins. PHB was less tightly bound to LDL than to other plasma components; the polymer could be isolated from LDL by extraction with chloroform, or by digestion with alkaline hypochlorite, but it could not similarly be recovered from VLDL or albumin. PHB in the LDL correlated positively with total plasma cholesterol and LDL cholesterol, and negatively with HDL cholesterol. The wide concentration range of PHB in plasma, its presence in VLDL and LDL and absence in HDL, coupled with its physical properties, suggest it may have important physiological effects.

Binding Sites

Orthoterminal correction of coexisting d-transposition of the great arteries, subpulmonary stenosis, and a complete form of atrioventricular canal.

This report outlines orthoterminal correction in an 8-year-old boy with coexisting d-transposition of the great arteries (d-TGA), subpulmonary stenosis, and a complete form of atrioventricular canal (CAVC). The repair consisted of covering the tricuspid valve and atrial part of the atrioventricular canal with a Dacron patch and inserting a valve-containing conduit between the then isolated right atrium and the pulmonary artery to create a venous outlet. The patient's exercise tolerance has improved remarkably. The arterial oxygen saturation has risen from 86 to 90 per cent. A plea is made to expand the indications for orthoterminal correction to patients in whom the severity of the heart malformation precludes application of well-established methods of surgical repair.

Child

Successful correction of total anomalous pulmonary venous connection in a 2.5 kilogram premature neonate.

A 16 day old 2.5 kg premature infant with total anomalous pulmonary venous drainage to the coronary sinus was successfully treated with use of profound hypothermia and total circulatory arrest. To the best of our knowledge, this neonate is the smallest to successfully undergo correction of this anomaly. A plea is made for a more aggressive approach in early recognition and assessment of these critically ill infants, followed by early surgical correction.

Age Factors

Dacron conduit with a stented porcine xenograft valve in the anatomic correction of transposition of the great arteries and subpulmonary stenosis.

A stented porcine xenograft valve, sutured into a woven Dacron tubular graft, has been used in the anatomic correction of D-loop, D-transposition of the great arteries, and subpulmonary stenosis. The main advantage of this technique is its simplicity and practicality, as both Dacron tubular grafts and stented porcine xenograft valves are commercially available.

Adolescent

Laboratory stress testing to assess real-life cardiovascular reactivity.

Thirty-six normotensive adults received laboratory stress testing (mental arithmetic, short-term memory, isometric handgrip, cold pressor tests) and 24-hour ambulatory blood pressure monitoring on two work days separated by a month. Laboratory and ambulatory measures of cardiovascular reactivity had low test-retest reliability. Increases in blood pressure during the memory and cold pressor tests were related to measures of reactivity obtained outside the laboratory (waking blood pressure variability, responses to home and work environments). However, the portion of ambulatory reactivity accounted for by laboratory reactivity was small. In the best case (r = 0.43), cold pressor diastolic pressure explained only 19% of diastolic pressure variability in the natural environment. Laboratory-ambulatory disagreement in reactivity was related to interindividual variability in physical activity on the day of ambulatory monitoring.

Adult

Ambulatory monitoring to assess real-life cardiovascular reactivity in Type A and Type B subjects.

The blood pressure (BP) of 107 normotensive adults, classified as either Type A or Type B, was monitored for 24 hours on two workdays a month apart. Daytime BP measures were adjusted for sleep BP measures to estimate behavioral ('higher') regulatory influences on BP that were relatively freed from nonbehavioral ('lower') influences. Adjusted daytime diastolic BP variability and diastolic BP levels during four common activities (talking, walking, drinking a caffeinated beverage, drinking an alcoholic beverage) were higher in Type A subjects than in Type B subjects. The results imply that Type A behavior itself, directly or indirectly, caused BP hyper-responsiveness to the stressors of routine daily living in the natural environment. Potential "carryover" of BP effects from wakefulness to sleep and potential incomplete removal of sleep BP variance from daytime BP variance limit the certainty of the above interpretation of results.

Adult